| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-11 04:44:57 UTC |
|---|
| Updated at | 2022-09-11 04:44:57 UTC |
|---|
| NP-MRD ID | NP0309866 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 17-carbamimidamido-3-hydroxy-n-[5,8,11,14,17-pentahydroxy-6-(c-hydroxycarbonimidoylmethyl)-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-12-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]heptadecanimidic acid |
|---|
| Description | N-[12-(butan-2-yl)-5,8,11,14,17-pentahydroxy-6-[(C-hydroxycarbonimidoyl)methyl]-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-17-carbamimidamido-3-hydroxyheptadecanimidic acid belongs to the class of organic compounds known as cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating. Based on a literature review very few articles have been published on N-[12-(butan-2-yl)-5,8,11,14,17-pentahydroxy-6-[(C-hydroxycarbonimidoyl)methyl]-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-17-carbamimidamido-3-hydroxyheptadecanimidic acid. |
|---|
| Structure | CCC(C)C1N=C(O)C(CC(C)C)N=C(O)C(N=C(O)CC(O)CCCCCCCCCCCCCCNC(N)=N)C(C)OC(=O)C(C)N=C(O)C(CC(O)=N)N=C(O)C(N=C1O)C(C)O InChI=1S/C45H82N10O11/c1-8-27(4)36-41(62)55-37(29(6)56)42(63)52-33(25-34(46)58)39(60)50-28(5)44(65)66-30(7)38(43(64)51-32(23-26(2)3)40(61)54-36)53-35(59)24-31(57)21-19-17-15-13-11-9-10-12-14-16-18-20-22-49-45(47)48/h26-33,36-38,56-57H,8-25H2,1-7H3,(H2,46,58)(H,50,60)(H,51,64)(H,52,63)(H,53,59)(H,54,61)(H,55,62)(H4,47,48,49) |
|---|
| Synonyms | | Value | Source |
|---|
| N-[12-(Butan-2-yl)-5,8,11,14,17-pentahydroxy-6-[(C-hydroxycarbonimidoyl)methyl]-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-17-carbamimidamido-3-hydroxyheptadecanimidate | Generator |
|
|---|
| Chemical Formula | C45H82N10O11 |
|---|
| Average Mass | 939.2100 Da |
|---|
| Monoisotopic Mass | 938.61645 Da |
|---|
| IUPAC Name | N-[12-(butan-2-yl)-5,8,11,14,17-pentahydroxy-6-[(C-hydroxycarbonimidoyl)methyl]-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]-17-carbamimidamido-3-hydroxyheptadecanimidic acid |
|---|
| Traditional Name | 17-carbamimidamido-3-hydroxy-N-[5,8,11,14,17-pentahydroxy-6-(C-hydroxycarbonimidoylmethyl)-9-(1-hydroxyethyl)-3,19-dimethyl-15-(2-methylpropyl)-2-oxo-12-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-18-yl]heptadecanimidic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCC(C)C1N=C(O)C(CC(C)C)N=C(O)C(N=C(O)CC(O)CCCCCCCCCCCCCCNC(N)=N)C(C)OC(=O)C(C)N=C(O)C(CC(O)=N)N=C(O)C(N=C1O)C(C)O |
|---|
| InChI Identifier | InChI=1S/C45H82N10O11/c1-8-27(4)36-41(62)55-37(29(6)56)42(63)52-33(25-34(46)58)39(60)50-28(5)44(65)66-30(7)38(43(64)51-32(23-26(2)3)40(61)54-36)53-35(59)24-31(57)21-19-17-15-13-11-9-10-12-14-16-18-20-22-49-45(47)48/h26-33,36-38,56-57H,8-25H2,1-7H3,(H2,46,58)(H,50,60)(H,51,64)(H,52,63)(H,53,59)(H,54,61)(H,55,62)(H4,47,48,49) |
|---|
| InChI Key | PFOSRPXICLQBQM-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cyclic depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids) connected in a ring. The residues are commonly but not necessarily regularly alternating. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Peptidomimetics |
|---|
| Sub Class | Depsipeptides |
|---|
| Direct Parent | Cyclic depsipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclic depsipeptide
- Macrolactam
- Alpha-amino acid ester
- Alpha-amino acid or derivatives
- Cyclic carboximidic acid
- Secondary alcohol
- Lactone
- Guanidine
- Carboxylic acid ester
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Polyol
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Carboximidic acid derivative
- Carboximidic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Imine
- Carbonyl group
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|